Microfluidic Device System Market

Microfluidic Device System Market - Global Industry Analysis, Trend, Size, Share and Forecast 2016 - 2024

Global Microfluidic Device System Market: Snapshot

In the last few years, the developments of microfluidic components and tools have been enthralling for the life science and pharmaceutical industries. Moreover, further developments are seen by various developing analytical applications in the several end user industries. It has been the major technology to engineer microminiaturized medical devices. Though there are various uses of this technology, but popularity of microfluidic components have increased largely in making lab-on-a-chip system. In addition, various advantages of the microfluidic components is cheap and provides swift test results that has grown its importance for making biological and chemical analyses.  Advancements made in point of care testing is likely to further expand the application of microfluidic device systems.

Other advantages of microfluidic components and tools has cheap cost of diagnostic procedures and limited use of reagents. Recently, microfluidic device system has observed numerous favorable applications in the areas of proteomics and genomics, creating many opportunities for players in the market. 

The global microfluidic device system market is expected to expand at a healthy 22.8% CAGR throughout the forecast period between 2013 and 2019. During the projected period the market to touch US$5.2 bn by 2019.

Wide Application of Microfluidic Devices System to Boost Market Growth 

The global microfluidic device system market is categorized on the basis of application, material, and industry type. The application of the microfluidic device system is seen in pharmaceuticals and life science, drug delivery, clinical and veterinary diagnostics, analytical devices, environmental and industrial, and point of care testing. Among these applications, clinical and veterinary diagnostic segment held the largest share in the market. However, it has been projected that in the coming years, the point of care testing segment could show a remarkable growth rate in the global microfluidic device system market over the forecast period.

According to the industry type, the market is segmented into pharmaceuticals, in-vitro diagnostics, and medical devices. Among these segments, the in-vitro diagnostics is the largest user of microfluidic device system and is expected to reach a valuation of US$ 3.3 bn by the end 2019. In addition, during the forecast tenure, the medical devices segment is also anticipated to increase the use of microfluidic device system that may boost the demand in the market. Based on type of material, the global market is further divided into glass, polymer, and silicon.

Low Cost Of Microfluidic Platforms In Point Of Care Testing To Rise In Developing Regions

On the regional front, the global microfluidic device system is categorized into North America, South America, Asia Pacific, Europe, and the Middle East and Africa. Out of these, North America possessed the key market share. Growing development of purpose-oriented and new microfluidic device systems are considered as the major factors for the growth the microfluidic device system market in the region.

In the meantime, the demand for medical devices is growing largely in Asia Pacific, whereas, point of care testing is the fastest growing application in the microfluidic device system market. Over the forecast period, Asia Pacific is anticipated to expand at a promising CAGR. Introduction of low-cost and portable microfluidic platforms in point of care testing in various emerging economies are supporting the growth of market in this region.

Based on the vendor landscape, the report has critically analyzed several leading players in the market. To mention a few players in the global microfluidic device system market are Abbott Laboratories, Becton Dickinson and Company, Siemens Healthcare, Agilent Technologies, Fluidigm Corporation, Roche Diagnostics, and Bio-Rad Laboratories.

     
    Chapter 1 Preface 11
    1.1 Report Description 11
    1.2 Research Methodology 12
          1.2.1 Sources 12
                  1.2.1.1 Secondary Research 12
                  1.2.1.2 Primary Research 12
                  1.2.1.3 Assumptions 13
     
    Chapter 2 Executive Summary 14
     
    Chapter 3 Industry Analysis 16
    3.1 Introduction 16
    3.2 Market Drivers and Opportunities 18
          3.2.1 Rising demand for point of care testing 18
          3.2.2 Miniaturization of chips, reduces cost of testing 19
          3.2.3 Increasing demand of microfluidic device in genomics and proteomics 19
          3.2.4 Change in material mix provides new opportunities for new players in the market 20
    3.3 Restraints and Challenges 20
          3.3.1 Strict regulatory requirements 20
          3.3.2 Geometrical and surface chemistry issues are a challenge for microfluidics 21
     
    Chapter 4 Market Trends 23
    4.1 Rising number of collaborations and partnerships 23
    4.2 Rising number of product innovations 24
     
    Chapter 5 Porters Five Force Analysis 25
    5.1 Bargaining power of buyers 25
    5.2 Bargaining power of suppliers 25
    5.3 Threat of new entrants 26
    5.4 Threat of substitutes 26
    5.5 Degree of competition 26
     
    Chapter 6 Global Market Size and Forecast 27
     
    Chapter 7 Segment Analysis – by Material 34
    7.1 Glass 34
    7.2 Polymer 36
    7.3 Silicon 38
     
    Chapter 8 Segment Analysis – by Industry 41
    8.1 In-vitro diagnostics 41
    8.2 Pharmaceuticals 43
    8.3 Medical Devices 48
     
    Chapter 9 Segment Analysis – by Application 52
    9.1 Point of care testing 52
    9.2 Pharmaceutical and life science research 54
    9.3 Drug delivery 57
    9.4 Analytical devices 59
    9.5 Clinical and veterinary diagnostics 62
    9.6 Environment and Industrial 64
     
    Chapter 10 Regional Analysis 68
    10.1 North America 68
    10.2 Europe 70
    10.3 Asia 73
    10.4 Rest of the World 75
     
    Chapter 11 Competitive Landscape 76
     
    Chapter 12 Company Profiles 77
    12.1 Roche Diagnostics 77
            12.1.1 Overview 77
            12.1.2 Products and segment 77
            12.1.3 Financial Performance 78
            12.1.4 Strategic Development 78
    12.2 Abbott Laboratories 80
            12.2.1 Overview 80
            12.2.2 Products and segment 80
            12.2.3 Financial Performance 81
            12.2.4 Strategic Developments 82
    12.3 Siemens Healthcare 83
            12.3.1 Overview 83
            12.3.2 Products and segment 83
            12.3.3 Financial Performance 84
            12.3.4 Strategic Development 84
    12.4 Agilent Technologies Inc 85
            12.4.1 Overview 85
            12.4.2 Products and segment 85
            12.4.3 Financial Performance 86
    12.5 Fluidigm Corporation 87
            12.5.1 Overview 87
            12.5.2 Products and segment 87
            12.5.3 Financial Performance 88
            12.5.4 Strategic Developments 88
    12.6 Bio- Rad Laboratories 91
            12.6.1 Overview 91
            12.6.2 Products and segment 91
            12.6.3 Financial Performance 92
            12.6.4 Strategic Developments 92
    12.7 Cepheid 94
            12.7.1 Overview 94
            12.7.2 Products and segment 94
            12.7.3 Financial Performance 94
            12.7.4 Strategic Developments 95
    12.8 RainDance Technologies 97
            12.8.1 Overview 97
            12.8.2 Products and segment 97
            12.8.3 Financial Performance 97
            12.8.4 Strategic Development 97
    12.9 Dolomite Centre 99
            12.9.1 Overview 99
            12.9.2 Products and segment 99
            12.9.3 Financial Performance 99
            12.9.4 Strategic Developments 99
    12.10 Micronit Microfluidics 101
            12.10.1 Overview 101
            12.10.2 Products and segment 101
            12.10.3 Financial Performance 101
    12.11 Johnson & Johnson 102
            12.11.1 Overview 102
            12.11.2 Product Segment 102
            12.11.3 Financial Performance 103
    12.12 Becton, Dickinson and Company 104
            12.12.1 Overview 104
            12.12.2 Products and Segments 104
            12.12.3 Financial performance 105
            12.12.4 Strategic Developments 105
    List of Tables
     
    TABLE 1 Market Snapshot: microfluidic device market (2013 & 2019) 14
    TABLE 2 Drivers for microfluidic devices market: Impact analysis 18
    TABLE 3 Restraints for microfluidic devices market: Impact analysis 20
    TABLE 4 Major collaborations and partnerships by microfluidic device companies (2011-2013) 23
    TABLE 5 Some of the products launched by various companies 24
    TABLE 6 Global microfluidic devices market size, by region 2009-2012 (USD million) 28
    TABLE 7 Global microfluidic devices market size, by region 2013-2019 (USD million) 28
    TABLE 8 Global microfluidic devices market size, by material 2009-2012 (USD million) 29
    TABLE 9 Global microfluidic devices market size, by material 2013-2019 (USD million) 30
    TABLE 10 Global microfluidic devices market size, by industry 2009-2012 (USD million) 31
    TABLE 11 Global microfluidic devices market size, by industry 2013-2019 (USD million) 31
    TABLE 12 Global microfluidic devices market size, by application 2009-2012 (USD million) 32
    TABLE 13 Global microfluidic devices market size, by application 2013-2019 (USD million) 33
    TABLE 14 Glass microfluidic devices market size, by region 2009-2012 (USD million) 35
    TABLE 15 Glass microfluidic devices market size, by region 2013-2019 (USD million) 35
    TABLE 16 Polymer microfluidic devices market size, by region 2009-2012 (USD million) 37
    TABLE 17 Polymer microfluidic devices market size, by region 2013-2019 (USD million) 38
    TABLE 18 Silicon microfluidic devices market size, by region 2009-2012 (USD million) 39
    TABLE 19 Silicon microfluidic devices market size, by region 2013-2019 (USD million) 40
    TABLE 20 In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million) 42
    TABLE 21 In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million) 42
    TABLE 22 Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million) 44
    TABLE 23 Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million) 45
    TABLE 24 Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million) 46
    TABLE 25 Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million) 46
    TABLE 26 Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million) 47
    TABLE 27 Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million) 48
    TABLE 28 Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million) 49
    TABLE 29 Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million) 50
    TABLE 30 Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million) 51
    TABLE 31 Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million) 51
    TABLE 32 Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million) 53
    TABLE 33 Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million) 54
    TABLE 34 Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million) 56
    TABLE 35 Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million) 56
    TABLE 36 Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million) 58
    TABLE 37 Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million) 59
    TABLE 38 Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million) 61
    TABLE 39 Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million) 61
    TABLE 40 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million) 63
    TABLE 41 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million) 64
    TABLE 42 Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million) 66
    TABLE 43 Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million) 66
    TABLE 44 The North American microfluidic devices market size, by country 2009-2012 (USD million) 69
    TABLE 45 The North American microfluidic devices market size, by country 2013-2019 (USD million) 70
    TABLE 46 The European microfluidic devices market size, by country 2009-2012 (USD million) 71
    TABLE 47 The European microfluidic devices market size, by country 2013-2019 (USD million) 72
    TABLE 48 The Asian microfluidic devices market size, by country 2009-2012 (USD million) 74
    TABLE 49 The Asian microfluidic devices market size, by country 2013-2019 (USD million) 75
    TABLE 50 Roche Diagnostics major product categories 77
    TABLE 51 Abbott Laboratories major product categories 80
    TABLE 52 Siemens Healthcare major product categories 83
    TABLE 53 Agilent Technologies major product categories 85
    TABLE 54 Major Fluidigm Corporation products and its application 87
    TABLE 55 Major Bio-Rad laboratories products and categories 91
    TABLE 56 Major Cepheid products and categories 94
    TABLE 57 Major RainDance Technologies products and its applications 97
    TABLE 58 Major Dolomite Centre products and categories 99
    TABLE 59 Major Micronit Microfluidics products and categories 101
    TABLE 60 Major Johnson & Johnson segments and products 102
    TABLE 61 Major Becton, Dickinson and Company segments and products 104

    List of Figures 

     

    FIG. 1 Applications of Microfluidics 16

    FIG. 2 Functions of Microfluidics 17

    FIG. 3 Aging population in major regions (% 2000-2050) 18

    FIG. 4 Microfluidic Device Market: Porters Five Force Analysis 25

    FIG. 5 Global microfluidic device market, by region 2013 (% share) 27

    FIG. 6 Global microfluidic device market, by material 2013 (% share) 29

    FIG. 7 Global microfluidic device market, by industry 2013 (% share) 30

    FIG. 8 Global microfluidic device market, by application 2013 (% share) 32

    FIG. 9 Glass microfluidic device market, by region 2013 (% share) 34

    FIG. 10 Polymer microfluidic device market, by region 2013 (% share) 36

    FIG. 11 Silicon microfluidic device market, by region 2013 (% share) 39

    FIG. 12 In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share) 41

    FIG. 13 Pharmaceutical industry in microfluidic device market, by region 2013 (% share) 43

    FIG. 14 Pharmaceutical industry in microfluidic device market, by product 2013 (% share) 45

    FIG. 15 Chips for lab analytics in microfluidic device market, by product 2013 (% share) 47

    FIG. 16 Medical device industry in microfluidic device market, by region 2013 (% share) 49

    FIG. 17 Medical devices industry in microfluidic device market, by product 2013 (% share) 50

    FIG. 18 Microfluidic device material used in point of care testing in 2010 (% share) 52

    FIG. 19 Point of care testing in microfluidic device market, by region 2013 (% share) 53

    FIG. 20 Microfluidic device material in pharmaceutical and life science research in 2010 (% share) 55

    FIG. 21 Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share) 55

    FIG. 22 Microfluidic device material in drug delivery in 2010 (% share) 57

    FIG. 23 Drug delivery in microfluidic device market, by region 2013 (% share) 58

    FIG. 24 Microfluidic device material in analytical devices in 2010 (% share) 60

    FIG. 25 Analytical Devices in microfluidic device market, by region 2013 (% share) 60

    FIG. 26 Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share) 62

    FIG. 27 Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share) 63

    FIG. 28 Microfluidic device material in environment and industrial application in 2010 (% share) 65

    FIG. 29 Environment and industrial application in microfluidic device market, by region 2013 (% share) 65

    FIG. 30 The North American microfluidic device market, by country 2013 (% share) 69

    FIG. 31 The European microfluidic device market, by country 2013 (% share) 71

    FIG. 32 The Asian microfluidic device market, by country 2013 (% share) 74

    FIG. 33 Competitive landscape of global microfluidic device market 76

    FIG. 34 Roche sales and net income 2011-2013 (USD Million) 78

    FIG. 35 Abbott Laboratories net sales and net earnings 2011-2013 (USD Million) 81

    FIG. 36 Siemens revenue and net income 2011-2013 (USD Million) 84

    FIG. 37 Agilent Technologies revenue and net income 2011-2013 (USD Million) 86

    FIG. 38 Fluidigm Corporation total revenue and net income 2011-2013 (USD Million) 88

    FIG. 39 Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million) 92

    FIG. 40 Cepheid sales and net income 2011-2013 (USD Million) 95

    FIG. 41 Johnson & Johnson sales and net earnings 2011-2013 (USD Million) 103

    FIG. 42 Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million) 105

Copyright © Transparency Market Research, Inc. All Rights reserved